What FDA wrote down, and handed over.

These are documents FDA has released, not a record of inspections that occurred. FDA posts a record only through proactive disclosure or the “three or more rule” (5 U.S.C. § 552(a)(2)(D)); it withholds records while a compliance action is open (21 CFR 20.64(d)), archives them after five years, and redacts portions under 21 CFR Part 20. In FDA’s own words, the absence of a facility here “should not be interpreted to mean that the facility has not been subject to appropriate regulatory oversight.” Record types are FDA’s own labels, carried through unchanged.